Study Stopped
Difficulties with recruitment
Imagine a Brighter Future: An Intervention to Improve Positive Emotions in Young People
IMAGINE-P
A Brief Intervention Targeting Anhedonia in Adolescents: a Feasibility Randomised Controlled Trial
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Depression is a common mental health problem that often begins during adolescence. Onset during adolescence can be disruptive to schoolwork and social relationships and if left untreated can lead to recurrence during adulthood, as well as the development of other mental health problems. Current treatments for depression (for both adults and young people) largely focus on reducing low mood and do not effectively tackle the other hallmark symptom of depression, anhedonia, which is characterised as a loss of enjoyment/ pleasure for previously enjoyed activities. Anhedonia is associated with increased risk of suicidality, so should be an important treatment target. Whilst some adult treatments are beginning to address anhedonia, little research has focussed on young people. It cannot be assumed that adult treatments will work identically in young people, particularly s their brains are still maturing compared to adults. The aim of this study is to complete a randomised feasibility trial, to see if it is possible to run a brief talking therapy for anhedonia in adolescent depression, by targeting one promising cognitive factor known to contribute to low positive affect: positive future mental imagery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2022
CompletedFirst Posted
Study publicly available on registry
August 19, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedMarch 9, 2023
May 1, 2022
1.8 years
May 20, 2022
March 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (17)
Feasibility outcome - 1: Uptake by schools
A percentage will be calculated for: the number of schools that express interest in the study divided the number of schools that do take part.
Through study completion, an average of 9 months
Feasibility outcome - 2: Uptake by participants
This will outcome will be assessed at the different stages of participant uptake: 1. the number of participants that completed the screen questionnaire divided by the number of students who received the screen questionnaire 2. the number of participants that accepted the invitation to pre-assessment divided by the number of participants that were eligible for pre-assessment from the screen 3. The number of participants randomised to intervention divided by the number of participants that completed the pre-assessment 4. The number of participants that completed the post-assessment divided by the number of participants that were randomised to intervention
Through study completion, an average of 9 months
Feasibility outcome - 3: Intervention completion
The number of participants successfully completing the intervention
Through study completion, an average of 9 months
Feasibility outcome - 4: Intervention drop-out
The number of participants that drop-out and the reasons for dropping out
Through study completion, an average of 9 months
Feasibility outcome - 5: Time Period
Time needed to collect and analyse data
Through study completion, an average of 9 months
Feasibility outcome - 6: Data completeness at pre-assessment
Data completeness for each questionnaire at pre-assessment
Through study completion, an average of 9 months
Feasibility outcome - 7: Missing Data at pre-assessment
Data missing and reasons for missing data at pre-assessment
Through study completion, an average of 9 months
Feasibility outcome - 8: Data completeness at post-assessment
Data completeness for each questionnaire at post-assessment
Through study completion, an average of 9 months
Feasibility outcome - 9: Missing Data at post-assessment
Data missing and reasons for missing data at post-assessment
Through study completion, an average of 9 months
Feasibility outcome - 10: Data completeness at follow-up assessment
Data completeness for each questionnaire at follow-up assessment
Through study completion, an average of 9 months
Feasibility outcome - 11: Missing Data at follow-up assessment
Data missing and reasons for missing data at follow-up assessment
Through study completion, an average of 9 months
Feasibility outcome - 12: Unexpected adverse effects
The number and nature of unexpected adverse effects will be recorded
Through study completion, an average of 9 months
Acceptability of the intervention - 1: Open questions for qualitative feedback of the programme
Qualitative questions on the feedback questionnaire: 1. What did you think of the programme? 2. Was there anything that made you more likely or less likely to take part in the programme? 3. How did you find completing the programme at school? 4. Was there anything about the programme that you really liked? 5. Was there anything about the training programme that you really didn't like? 6. What was the most important thing about the programme for you? 7. Would you recommend this to others who are experiencing difficulties with mood and self-esteem? If so why? Or why not? 8. Is there anything else you'd like to say about this programme?
Post-intervention (within 2 weeks of post intervention)
Acceptability of the intervention - 2: Satisfaction with the programme
Participants indicate how satisfied they were with the programme on a 5-point scale; minimum score: 1; maximum score 5. Higher scores indicate better outcome.
Post-intervention (within 2 weeks of post intervention)
Acceptability of the intervention - 3: Feedback on the number of sessions in the programme
Participants rate what they thought about the number of session on a 5-point scale. 1 = I would have liked 2+ less; 2= I would have liked 1-2 less; 3= I was happy with the number of sessions; 4= I would have liked 1-2 more; 5= I would have liked 2+ more. Minimum score: 1; maximum score 5.
Post-intervention (within 2 weeks of post intervention)
Acceptability of the intervention - 4: Extend the programme has helped
Participants rate the extent to which the programme helped them on a 5-point scale. Minimum score: 1; maximum score: 5; higher scores indicate better outcome.
Post-intervention (within 2 weeks of post intervention)
Acceptability of the intervention - 5: Recommend the programme to a friend
Participants rate if they would recommend the programme to a friend on a 5-point scale. 1= no, definitely not; 2= probably not; 3 = unsure; 4 = yes, probably; 5 = yes, definitely. Minimum score: 1; maximum score 5; higher scores indicate better outcome.
Post-intervention (within 2 weeks of post intervention)
Secondary Outcomes (10)
Mood and Feelings Questionnaire
Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Snaith-Hamilton Pleasure Scale
Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Positive and Negative Affect Schedule
Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
The Prospective Imagery Task
Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Autobiographical Memory Task
Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
- +5 more secondary outcomes
Study Arms (2)
Intervention: IMAGINE-P
EXPERIMENTALExperimental intervention: IMAGINE-POSITIVE targeting positive affect (IMAGINE-P): The intervention will combine aspects of Memory Specificity Training (MeST), which includes information about the links between memories and emotions, with Positive Prospective Mental Imagery (PPMI).
Control:
ACTIVE COMPARATORControl intervention: Non-directive supportive therapy (NDST) consists of individual sessions, with an empathetic, emotionally supportive practitioner and provides non-directive problem solving and monitoring. Using NDST will control for factors that may contribute to change, which are not active components e.g. speaking to an empathetic therapist. NDST will follow treatment guidelines.
Interventions
The intervention will combine aspects of Memory Specificity Training (MeST), which includes information about the links between memories and emotions, with Positive Prospective Mental Imagery (PPMI), to increase vividness and savouring of positive future images, in order to harness positive affect. IMAGINE-PA will follow a treatment manual and delivery will be accompanied by a therapy workbook.
Non-directive supportive therapy (NDST) consists of individual sessions, with an empathetic, emotionally supportive practitioner and provides non-directive problem solving and monitoring. Using NDST will control for factors that may contribute to change, which are not active components e.g. speaking to an empathetic therapist. NDST will follow treatment guidelines.
Eligibility Criteria
You may qualify if:
- Aged 14-19
- Informed consent
- Willing and able to engage in psychological therapy and complete assessments
- scoring above clinical cut-off on the MFQ (33 items; clinical cut-off ≥20, and showing high symptoms of anhedonia, as measured by the SHAPS ( 14 items; abnormal level of hedonic tone\>2).
You may not qualify if:
- Diagnosis of learning disability (but not difficulty e.g. dyslexia), diagnosis of Autism Spectrum Disorder, or significant head injury, neurological disorder or epilepsy
- Unable to fluently communicate in spoken English
- Unable to give informed consent
- High levels of current risk
- Currently receiving therapy (including school counselling)
- Experiencing psychotic symptoms or depressed in the postnatal period (participants with co-morbid physical illness or non-psychotic disorders such as anxiety will not be excluded)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Londonlead
- Mental Health Research UKcollaborator
Study Sites (1)
King's College London
London, SE5 8AB, United Kingdom
Related Publications (11)
Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, Gilmer WS, Dresselhaus TR, Thase ME, Nierenberg AA, Trivedi MH, Rush AJ. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry. 2007 Oct;164(10):1539-46. doi: 10.1176/appi.ajp.2007.06101757.
PMID: 17898345BACKGROUNDBridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry. 2009 Jan;166(1):42-9. doi: 10.1176/appi.ajp.2008.08020247. Epub 2008 Dec 1.
PMID: 19047322BACKGROUNDGabbay V, Johnson AR, Alonso CM, Evans LK, Babb JS, Klein RG. Anhedonia, but not irritability, is associated with illness severity outcomes in adolescent major depression. J Child Adolesc Psychopharmacol. 2015 Apr;25(3):194-200. doi: 10.1089/cap.2014.0105. Epub 2015 Mar 24.
PMID: 25802984BACKGROUNDPizzagalli DA. Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol. 2014;10:393-423. doi: 10.1146/annurev-clinpsy-050212-185606.
PMID: 24471371BACKGROUNDGiedd JN. The teen brain: insights from neuroimaging. J Adolesc Health. 2008 Apr;42(4):335-43. doi: 10.1016/j.jadohealth.2008.01.007.
PMID: 18346658BACKGROUNDDunn BD. Helping depressed clients reconnect to positive emotion experience: current insights and future directions. Clin Psychol Psychother. 2012 Jul-Aug;19(4):326-40. doi: 10.1002/cpp.1799. Epub 2012 Jun 5.
PMID: 22674611BACKGROUNDHolmes EA, Blackwell SE, Burnett Heyes S, Renner F, Raes F. Mental Imagery in Depression: Phenomenology, Potential Mechanisms, and Treatment Implications. Annu Rev Clin Psychol. 2016;12:249-80. doi: 10.1146/annurev-clinpsy-021815-092925. Epub 2016 Jan 15.
PMID: 26772205BACKGROUNDBurnett Heyes S, Lau JY, Holmes EA. Mental imagery, emotion and psychopathology across child and adolescent development. Dev Cogn Neurosci. 2013 Jul;5:119-33. doi: 10.1016/j.dcn.2013.02.004. Epub 2013 Mar 5.
PMID: 23523985BACKGROUNDPile V, Lau JYF. Looking forward to the future: Impoverished vividness for positive prospective events characterises low mood in adolescence. J Affect Disord. 2018 Oct 1;238:269-276. doi: 10.1016/j.jad.2018.05.032. Epub 2018 May 30.
PMID: 29894932BACKGROUNDPile V, Smith P, Leamy M, Blackwell SE, Meiser-Stedman R, Stringer D, Ryan EG, Dunn BD, Holmes EA, Lau JYF. A brief early intervention for adolescent depression that targets emotional mental images and memories: protocol for a feasibility randomised controlled trial (IMAGINE trial). Pilot Feasibility Stud. 2018 Jul 4;4:97. doi: 10.1186/s40814-018-0287-3. eCollection 2018.
PMID: 29997904BACKGROUNDLancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004 May;10(2):307-12. doi: 10.1111/j..2002.384.doc.x.
PMID: 15189396BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2022
First Posted
August 19, 2022
Study Start
September 1, 2022
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
March 9, 2023
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share
No plan for individual participant data